(Q44601814)

4 December 2017

Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients (English)

1 reference

10.1097/00001721-199112000-00004

Crossref

DOI

https://api.crossref.org/works/10.1097/00001721-199112000-00004

28 November 2022

1 reference

1 reference

3

Sandset PM

1 reference

4 December 2017

A. K. Lindahl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799658

28 November 2022

P. B. Jacobsen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799658

28 November 2022

U. Abildgaard

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1799658

28 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1799658

28 November 2022

publication date

1 December 1991

1 reference

full work available at URL

4 December 2017

http://journals.lww.com/00001721-199112000-00004

1 reference

10.1097/00001721-199112000-00004

Crossref

DOI

https://api.crossref.org/works/10.1097/00001721-199112000-00004

Blood Coagulation and Fibrinolysis

28 November 2022

published in

1 reference

4 December 2017

2

1 reference

4 December 2017

713-721

1 reference

4 December 2017

6

1 reference

10.1097/00001721-199112000-00004

4 December 2017

Identifiers

DOI

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1799658

28 November 2022

1 reference